Open AccessInterferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C
Author(s) -
Haruya Ishiguro,
Hiroshi Abe,
Nobuyoshi Seki,
Tomonori Sugita,
Yuta Aida,
Munenori Itagaki,
Satoshi Sutoh,
Noritomo Shimada,
Tomomi Furihata,
Akihito Tsubota,
Yoshifusa Aizawa
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i13.3904
Subject(s) - ribavirin , medicine , pegylated interferon , gastroenterology , genotype , hepatitis c virus , hepatitis c , immunology , virus , biology , biochemistry , gene
To evaluate interferon-λ3 (IFNL3) polymorphisms in response-guided pegylated interferon-α plus ribavirin (Peg-IFNα/RBV) therapy for genotype 2 (G2) chronic hepatitis C.